HK$36.56
0.77%
Hong Kong, Sep 21, 11:59 am HKT. Market open.
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Target price 2026 - Analyst rating & recommendation

JD Health International Classifications & Recommendation

Buy
87%
Hold
13%

JD Health International Price Target

Target Price HK$68.18
Price HK$36.28
Potential
Number of Estimates 17
17 Analysts have issued a price target JD Health International 2027 . The average JD Health International target price is HK$68.18. This is higher than the current stock price. The highest price target is
HK$97.75 169.44%
register free of charge
, the lowest is .
A rating was issued by 23 analysts: 20 Analysts recommend JD Health International to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2027 of . Most analysts recommend the JD Health International stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion HK$ 86.00 102.69
26.28% 19.41%
EBITDA Margin 6.99% 6.80%
17.47% 2.71%
Net Margin 7.32% 8.01%
2.28% 9.44%

18 Analysts have issued a sales forecast JD Health International 2026 . The average JD Health International sales estimate is

HK$103b
unlock
. This is
10.96% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HK$108b 16.43%
unlock
, the lowest is
HK$97.8b 5.66%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$86.0b 26.28%
2026
HK$103b 19.41%
unlock
2027
HK$118b 15.30%
unlock
2028
HK$136b 14.45%
unlock
2029
HK$154b 13.70%
unlock
2030
HK$170b 10.02%
unlock
2031
HK$185b 9.41%
unlock
2032
HK$201b 8.36%
unlock
2033
HK$216b 7.31%
unlock

19 JD Health International Analysts have issued a net profit forecast 2026. The average JD Health International net profit estimate is

HK$8.2b
unlock
. This is
13.05% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HK$9.0b 23.13%
unlock
, the lowest is
HK$6.9b 4.62%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$6.3b 29.16%
2026
HK$8.2b 30.72%
unlock
2027
HK$9.7b 17.38%
unlock
2028
HK$11.4b 17.97%
unlock
2029
HK$12.0b 5.52%
unlock
2030
HK$11.7b 2.99%
unlock
2031
HK$13.4b 15.24%
unlock
2032
HK$15.2b 12.92%
unlock
2033
HK$17.0b 11.94%
unlock

Net Margin

2025 7.32% 2.28%
2026
8.01% 9.44%
unlock
2027
8.16% 1.87%
unlock
2028
8.41% 3.06%
unlock
2029
7.80% 7.25%
unlock
2030
6.88% 11.79%
unlock
2031
7.25% 5.38%
unlock
2032
7.55% 4.14%
unlock
2033
7.88% 4.37%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share HK$ 1.97 2.56
27.92% 29.95%
P/E 14.16
EV/Sales 0.53

19 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International EPS is

HK$2.56
unlock
. This is
12.78% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HK$2.79 22.91%
unlock
, the lowest is
HK$2.16 4.85%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$1.97 27.92%
2026
HK$2.56 29.95%
unlock
2027
HK$3.01 17.58%
unlock
2028
HK$3.55 17.94%
unlock
2029
HK$3.74 5.35%
unlock
2030
HK$3.63 2.94%
unlock
2031
HK$4.19 15.43%
unlock
2032
HK$4.73 12.89%
unlock
2033
HK$5.29 11.84%
unlock

P/E ratio

Current 15.98 66.81%
2026
14.16 11.40%
unlock
2027
12.06 14.83%
unlock
2028
10.22 15.26%
unlock
2029
9.69 5.19%
unlock
2030
9.99 3.10%
unlock
2031
8.67 13.21%
unlock
2032
7.68 11.42%
unlock
2033
6.86 10.68%
unlock

Based on analysts' sales estimates for 2026, the JD Health International stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.58 77.61%
2026
0.53 9.28%
unlock
2027
0.46 13.26%
unlock
2028
0.40 12.62%
unlock
2029
0.35 12.06%
unlock
2030
0.32 9.10%
unlock
2031
0.29 8.59%
unlock
2032
0.27 7.72%
unlock
2033
0.25 6.81%
unlock

P/S ratio

Current 1.20 65.52%
2026
1.08 9.88%
unlock
2027
0.94 13.27%
unlock
2028
0.82 12.62%
unlock
2029
0.72 12.06%
unlock
2030
0.65 9.10%
unlock
2031
0.60 8.61%
unlock
2032
0.55 7.71%
unlock
2033
0.51 6.81%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today